MERTK and myeloid sarcoma: Although this association would need to be validated in order to exclude the possibility that the detected altered expression was not the result of contaminating CD4+ve monocytes, it has recently been shown that Mertk is expressed in the Th17+ve subset of CD4+ve T cells in mice following induction of experimental autoimmune encephalomyelitis, a mouse model of MS [39].